Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Stancek

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Acta Virologica|July 1, 1972
Distribution of antiviral and cell-inhibitory activity in interferon preparationsL Borecký, N Fuchsberger, V Hájnická, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Psychopharmaca and electroconvulsive therapy in relation to viral antibodies and interferon. Experimental and clinical studyH Libíkowa, D Stancek, V Wiedermann, et al.
Acta Virologica|July 1, 1986
Effect of influenza virus on the interaction of cytoskeleton with cell membranesO Krizanová, F Ciampor, E Závodská, et al.
Medical Microbiology and Immunology|January 1, 1975
Isolation and some serological and epidemiological data on the viruses recovered from patients with subacute thyroiditis de QuervainD Stancek, M Stanceková-Gressnerová, M Janotka, et al.
Acta Virologica|May 1, 1989
Mechanism of altered cytoskeleton organization in influenza virus infectionO Krizanová, F Ciampor, E Závodská, et al.
Vnitrni Lekarstvi|January 1, 1985
[HBsAg positive blood donors]J Holomán, J Glasa, D Stancek, et al.
Acta Virologica|March 1, 1988
Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illnessD Stancek, N Fuchsberger, L Borecký, et al.
Acta Virologica|September 1, 1990
Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis BD Stancek, V Hajnická, H Blaskovicová, et al.
Bratislavske Lekarske Listy|March 1, 1988
[Outpatient follow-up of HBsAg-positive blood donors]J Glasa, J Holomán, D Stancek, et al.
Ceskoslovenska Epidemiologie, Mikrobiologie, Imunologie|March 1, 1988
[Analysis of foci of viral hepatitis B in selected areas. Preliminary report]M Zacharová, A Milosovicová, J Cervenka, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Acta Virologica|July 1, 1972
Distribution of antiviral and cell-inhibitory activity in interferon preparationsL Borecký, N Fuchsberger, V Hájnická, et al.
Archivum Immunologiae Et Therapiae Experimentalis|January 1, 1977
Psychopharmaca and electroconvulsive therapy in relation to viral antibodies and interferon. Experimental and clinical studyH Libíkowa, D Stancek, V Wiedermann, et al.
Acta Virologica|July 1, 1986
Effect of influenza virus on the interaction of cytoskeleton with cell membranesO Krizanová, F Ciampor, E Závodská, et al.
Medical Microbiology and Immunology|January 1, 1975
Isolation and some serological and epidemiological data on the viruses recovered from patients with subacute thyroiditis de QuervainD Stancek, M Stanceková-Gressnerová, M Janotka, et al.
Acta Virologica|May 1, 1989
Mechanism of altered cytoskeleton organization in influenza virus infectionO Krizanová, F Ciampor, E Závodská, et al.
Vnitrni Lekarstvi|January 1, 1985
[HBsAg positive blood donors]J Holomán, J Glasa, D Stancek, et al.
Acta Virologica|March 1, 1988
Human interferon alfa therapy and hepatitis B virus markers in the serum of patients with chronic course of illnessD Stancek, N Fuchsberger, L Borecký, et al.
Acta Virologica|September 1, 1990
Transient increase of HBsAg levels following human IFN alpha treatment signalises the patient's response in chronic active hepatitis BD Stancek, V Hajnická, H Blaskovicová, et al.
Bratislavske Lekarske Listy|March 1, 1988
[Outpatient follow-up of HBsAg-positive blood donors]J Glasa, J Holomán, D Stancek, et al.
Ceskoslovenska Epidemiologie, Mikrobiologie, Imunologie|March 1, 1988
[Analysis of foci of viral hepatitis B in selected areas. Preliminary report]M Zacharová, A Milosovicová, J Cervenka, et al.
Pageof 5